Unique ID issued by UMIN | UMIN000026579 |
---|---|
Receipt number | R000030520 |
Scientific Title | Pharmacokinetics of mianserin suppository in Japanese elderly healthy volunteers -a pilot study |
Date of disclosure of the study information | 2017/03/16 |
Last modified on | 2020/03/22 16:21:16 |
Pharmacokinetics of mianserin suppository in Japanese elderly healthy volunteers -a pilot study
Pharmacokinetics of mianserin suppository in healthy volunteers
Pharmacokinetics of mianserin suppository in Japanese elderly healthy volunteers -a pilot study
Pharmacokinetics of mianserin suppository in healthy volunteers
Japan |
delirium
Psychiatry |
Malignancy
NO
To investigate the pharmacokinetics of a single rectal administration of mianserin 20 mg suppository in elderly healthy volunteers
PK,PD
Pharmacokinetics parameters (area under the blood concentration time curve, maximum drug concentration, time of maximum drug concentration, half-life)
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
A single dose of mianserin 30 mg suppository will be rectally administered
Blood sampling will be conducted 7 times (at pre, 0.5, 1, 2, 4, 6, 8, 10, 24, 36, 48 hours).
65 | years-old | <= |
76 | years-old | > |
Male
Healthy volunteers enrolled this study must be agreement with the following criteria:
1. Age between 65 and 75
2. Male
3. Subjects are competent to consent, keep the rule of this study and are able to report self condition
4. Subjects who are judged eligible by the investigator in several series of medical check
1. Subjects who have inappropriate medical history (ex., drug abuse, alcoholism, any kind of heart, liver, kidney, lung, eye, blood diseases and digestive system disorder, etc.) or who are ingested medicines during this study.
2. Smoker.
3. Any drug allergy.
4. Subjects who are using excessive alcohol regularly (cannot keep abstinence for study period).
5. Participation in any clinical trial within the last 3 months.
6. Subjects who are inadequate for enrollment judged by the investigators.
3
1st name | Shuichi |
Middle name | |
Last name | Nawata |
Showa University
School of Pharmacy
142-8555
1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555.
03-3784-8000
nawa_shu@cmed.showa-u.ac.jp
1st name | Shuchi |
Middle name | |
Last name | Nawata |
Showa University
School of Pharmacy
142-8555
1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555.
03-3784-8000
nawa_shu@cmed.showa-u.ac.jp
Department of Hospital Pharmaceutics
Grants-in-Aid for Scientific Research
Other
Clinical Research Institute for Clinical Pharmacology and Therapeutics
Showa University Karasuyama Hospital
lnstitutional Review Board of ShowaUniversity Karasuyama Hospital
6-11-11 Kitakarasuyama,Setagaya-ku,Tokyo,157-8577 Japan
03-3300-5231
scri@ofc.showa-u.ac.jp
NO
昭和大学附属烏山病院内 昭和大学臨床薬理研究所(東京都)
2017 | Year | 03 | Month | 16 | Day |
http://www.showa-u.ac.jp/SUHK/guide/irb/report.html
Published
http://www.jscpt.jp/journal/pdf/j50_2.pdf
3
The effects of 20mg mianserin suppositories were evaluated in three healthy older male adults. Mianserin concentration in blood was measured using gas chromatography-mass spectrometry. tmax was 14.7(8.1)h; Cmax was 7.0
(1.4)ng mL; AUC0-48 was 196.7(19.6)h ng/mL
2020 | Year | 03 | Month | 22 | Day |
healthy older male adults
Open call for participants
no
pharmacokinetics of mianserin suppositories
Completed
2016 | Year | 09 | Month | 12 | Day |
2017 | Year | 04 | Month | 14 | Day |
2017 | Year | 02 | Month | 17 | Day |
2017 | Year | 03 | Month | 31 | Day |
2017 | Year | 03 | Month | 31 | Day |
2017 | Year | 03 | Month | 31 | Day |
2017 | Year | 03 | Month | 31 | Day |
2017 | Year | 03 | Month | 16 | Day |
2020 | Year | 03 | Month | 22 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030520
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |